US EditionGOP leader Steve Scalise gives update on cancer treatment, reveals wife knew something was wrong over phone
- Steve Scalise, the No. 2 House Republican, returned to the U.S. Capitol for the first time since being diagnosed with multiple myeloma, a blood cancer. His treatment is ongoing and will be evaluated over the next few months.
- Despite his diagnosis, Scalise plans to continue working in Congress and receiving chemotherapy treatment in Washington. He has limited his in-person interactions due to taking precautions to protect his immune system.
- Scalise's diagnosis comes at a challenging time for House Republicans, as they are dealing with issues such as a potential government shutdown and launching an impeachment inquiry into President Joe Biden.
18 Articles
18 Articles
No. 2 House Republican Steve Scalise returns to the Capitol after his blood cancer diagnosis
WASHINGTON (AP) — Rep. Steve Scalise, the No. 2 House Republican, returned to the U.S. Capitol on Thursday for the first time since being diagnosed with a blood cancer known as multiple myeloma and told reporters his chemotherapy treatment is underway. “It's kind of a few months process. They don't know yet how long it's going to be — four months, six months — but they want to continue to evaluate and say, 'OK, how's he doing? How's the treatmen…
GOP leader Steve Scalise gives update on cancer treatment, reveals wife knew something was wrong over phone
House Republican Majority Leader Steve Scalise returned to work at the Capitol Thursday for the first time since his cancer diagnosis in August and said treatment is "going well."
No. 2 House Republican Steve Scalise returns to the Capitol after his blood cancer diagnosis
WASHINGTON (AP) — Rep. Steve Scalise, the No. 2 House Republican, returned to the U.S. Capitol on Thursday for the first time since being diagnosed with a blood cancer known as multiple myeloma and told reporters his chemotherapy treatment is underway. “It's kind of a few months process. They don't know yet how long it's going to be — four months, six months — but they want to continue to evaluate and say, 'OK, how's he doing? How's the treatmen…
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
